Methylene Blue (50 mg/10ml)
CMUH114-REC1-108
Phase 1 small_molecule active
Quick answer
Methylene Blue (50 mg/10ml) for Head and Neck Cancer is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Head and Neck Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active